Benzinga | May 21, 2021 09:34AM EDT

Argus Research Maintains Buy on Clorox, Lowers Price Target to $206

Argus Research analyst John Staszak maintains Clorox (NYSE:CLX) with a Buy and lowers the price target from $230 to $206.